Infectious disease caused by SARS-CoV-2
HTRL COVID-19 Core Facility
The Howard T. Ricketts Laboratory (HTRL) is a regional biocontainment laboratory with several designated biosafety level 3 (BSL-3) laboratories, which are required for biodefense-related and emerging infectious disease research.
The HTRL is on the campus of Argonne National Laboratory and is managed by the University of Chicago and BSD under the leadership of Dominique Missiakas, Professor of Microbiology.
At the start of the COVID-19 crisis, we decided to start a fee-for-service core facility at HTRL dedicated to SARS-CoV2 research projects requiring BSL-3 level containment. Glenn Randall, Professor of Microbiology, is leading this new core facility together with Dr. Missiakas. The core will operate via HTRL staff members performing fee-for-service assays (including several viral replication and neutralizing antibody assays) and small animal studies.
Our most requested assays are listed below. If you have a project that you would like to submit to this core, please contact Andrea DeRosier (firstname.lastname@example.org) for more information on the prioritization and approval process.
Animal Model Infections
- Drug testing
- Vaccination studies
- Blood/organ collection
- Cytopathic Effect assay
- Plaque assay
- TCDi50 assay
- Neutralizing antibody assay
- Spike IHC screening
- RNA extraction
- First-strand cDNA synthesis
- Quantitative RT-PCR
COVID-19 Core Services
|TCID 50 96 Well Plate||$162||$162|
|Cytopathic Effect 96 Well Plate||$875||$875|
|Spike IHC Screening 96 Well Plate||$586||$586|
|Plaque Assay 24 Well Plate||$625||$625|
|Neutralizing Antibodies 96 Well Plate||$208||$208|
|Mouse Per Diem||$1.59 Per Item||$7.29 Per Item|